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CASE REPORT
A22-year-oldladywasreferredtotherespirology
departmentofatertiaryreferralhospitalforfurther
assessment of newly diagnosed pulmonary
arteriovenous; malformations (AVMs) She had
initially presented to a paediatric department at
the age of 8 years for investigation of recurrent
epistaxis and iron deficiency anaemia. Her stool
was identified as being positive forfaecal occult
blood and following further gastrointestinal
investigation, multiple polyps were discovered
throughout her gastrointestinal tract (Fig. 1).
Histological examination determined the polyps
to be hamartomas and she was diagnosed as
having generalisedjuvenile polyposis. She had a
subtotal colectomy aged 9 years and a
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Fig 1 Small bowel series demonstrating several filling
defects consistent with polyps in the jejunum.
The patient was post colectomy at this stage.
panproctocolectomy with subsequent fashioning
of an ileal pouch anastomosis aged 19 years.
Duringthisperiodoftime she continued to suffer
from recurrent epistaxis and had numerous
embolisation and surgicalprocedures carried out
inanattempttoalleviatethisproblem. Withinthe
last 2 years, multiple telangiectasias were
identifiedonthevermillionborderofherlips and
underlying Hereditary Haemorrhagic
Telangiectasia (HHT) or Osler-Weber-Rendu
Syndromewassuspected. Shehadnodocumented
family history of this or juvenile polyposis,
however her father had been rejected several
times from being a blood donor because of
anaernia. A magnetic resonance imaging (MRI)
scan ofthebraindidnot show any evidence ofan
intracranial AVM. Computed tomography (CT)
scan of her chest did however identify multiple
pulmonary AVMs, thuspromptingherreferral to
respirology.
At this presentation there was no history of
dyspnoea, cough, haemoptysis or blackouts. On
physicalexaminationshehadfacialtelangiectasia,
which was most marked adjacent to her bottom
lip. There was no evidence ofanaernia or central
cyanosis. Respiratory rate was normal and there
was no finger clubbing. Apart from scars from
her previous abdominal surgery, physical
examination was otherwise unremarkable.
Haematological investigations revealed a
haemoglobin of 122 g/L andnormalelectrolytes.
Oxygen saturation was 86% on room air. An
arterial blood gas revealed pH 7.40, pCO2 40
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mmHg,pO252mmHg,HCO3 25 mmol/LandBE
0. Pulmonary function tests showed mildly
impaired diffusion capacity at 71% predicted,
butwas otherwise within normal limits. Arepeat
spiral CT scan of chest (Fig.2) using a high
resolution protocol was performed to accurately
Fig 2. CT scan ofchestshowing thetypical serpiginous
characteristic of AVMs within the lingula and
right middle lobe.
determine the size and distribution of the
pulmonary AVMs. This identified multiple
pulmonaryAVMsintherightmiddlelobe,lingula
and left lower lobe. These were later confirmed
by a pulmonary angiogram (Fig.3). Coil
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Fig 3. Pulmonary artceriora confiring the naturel srinofs
thercersi AVM AVswtin the lingula pirtemosatin.
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Fig 4. Post successful coil embolisation ofthelingular
AVM.
embolisationoftheAVMs wasattemptedandthe
largest AVM in the lingula was successfully
occluded, without complication (Fig.4). The
patientis to return forfurtherembolisation ofher
remaining AVMs.
Discussion
Hereditaryhaemorrhagictelangiectasiais agroup
of autosomal dominant disorders with genetic
linkages that have been established to
chromosome 9q3 (HHT 1) and 12q 13 (HHT2),
although it is possible that genes on other
chromosomesmayalsobeinvolved11.Theclinical
diagnosis is made with two or moreof the
following: recurrent epistaxis, telangiectasis
elsewhere than in the nasal mucosa, evidence of
autosomal dominant inheritance or visceral
involvement. Visceral involvement includes
AVMs found in thepulmonary, gastrointestinal,
hepatic or central nervous system circulations.
Juvenilepolyposisis also anautosomaldominant
condition featuring the development ofmultiple
hamartomatous polyps, most commonly in the
colon,~~~~~~~~~~~ butE?' whic can.......................... atslgso ocu in: th stoac or .......
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and anaemia. An association between juvenile
polyposis and HHT has only rarely been
previously documented. Initially in 1982, Cox et
al[3] described a mother and daughter with
generalisedjuvenilepolyposis,pulmonaryAVMs
andseveredigitalclubbing. Bothpatientsfulfilled
thediagnosticcriteriaforHHT. Sincethenfurther
cases have intermittently been identifiedE21'48,
culminating in a short series ofcases by Ballauff
and Koletzko in 1999 9'.
In HHTI, the genetic mutation at chromosome
9q3 has been identified as involving endoglin.
This encodes anintegral membrane glycoprotein
that binds transforming growth factor B (TGFB).
In HHT2, the abnormal gene on chromosome
12ql3 encodes activin receptor-like kinase 1
(ALK-1), a cell surface receptor for the TGFB
superfamily of ligands8]. When undergoing
investigation for HHT, our patient had normal
endoglin levels, making it likely she had either
HHT2 or a mutation in apreviously unidentified
gene.
Injuvenile polyposis, although the exact genetic
abnormality is not known, it ha been proposed
that mutations in the tumour suppressor gene
PTENonchromosome lOqmayberesponsiblein
certain cases 2]. Juvenile polyposis has also been
described in association with other genetic
syndromes including Gorlin Syndrome and
Bannayan-Riley-Ruvalcaba Syndrome, as well
as HHT, suggesting a certain genetic
heterogeneity in its aetiology 21. It is likely that
the genetic abnormality associating HHT and
juvenilpolyposisislinked, andalthoughthislink
has notyetbeenidentified, itis statistically more
likely than both these rare diseases existing as a
coincidence~[3 .
Theimportanceofdiagnosingjuvenilepolyposis
isthatalthoughthepolyps arehamartomas, there
is an overall increased risk of gastrointestinal
malignancy in these patients when compared to
the general population[I'0. Colectomy is often
requiredwithcontinued surveillance oftheupper
gastrointestinal tract.
Itisimportanttohighlightthatanassociationcan
occur between these two conditions. Early
recognitionofthisassociationallowsthepertinent
management problems of each syndrome to be
addressed. With regard to HHT, pulmonary and
intracranial AVMs are of particular concern, as
they may be clinically silent lesions, which can
result in sudden morbidity or deathr11. Patients
with pulmonary AVMs are much more common
andatriskofstrokeorcerebralabscess secondary
to the pulmonary systemic shunt, Antibiotic
prophylaxis is thus mandatory in these patients
undergoing dental procedures and during
endoscopy. Endoscopymaybeperformedforthe
investigation of gastrointestinal haemorrhage,
either secondary to mucosal telangiectasia or
hamartomatous polyps.
Screening protocols for pulmonary AVMs have
been suggested to identify persons whose risk of
pulmonary AVMs is sufficient for diagnostic
imaging to be warranted. It is most indicated in
patientswithalowP02orfamilyhistoryofAVM,
but should be considered in all patients with
HHT. A recent report from a Canadian group
showedthat screening with chestradiograph and
pulseoximetrywasinsufficientil1. Theyreported
that initial screening by clinical examination
followedbymeasurementofPaO2whilebreathing
100% oxygen is warrantedE113. This same group
recently showed the added advantage ofagitated
saline contrast echocardiography as a useful
adjunctive test. In their prospective study it was
the only positive screening test in 31 % of
patients'21. This group have also reported their
experience with diffuse pulmonary AVMs and
reportedthattranscatheterembolectomyreduced
the risk of neurologic complicationsE'31. They
reported thatthepatients can live formany years
and lead productive lives but they do not
recommendlungtransplantation as survival with
the disease is difficult to predict and they had a
perioperative transplant deatht13 .
In our hands screening for pulmonary AVMs is
easily performed with spiral computed
tomography. Screening for intracranial AVM is
achieved with magnetic resonance imaging,
althoughtheindicationforthisislesswelldefined
in the absence ofheadache or a family history of
intracranial AVME'3. It is advised that persons
affectedby, oratriskfor, HHTwhohaveafamily
history of pulmonary or cerebral AVMs should
undergo pulmonary screening at puberty, or
sooner ifthe family history includes prepubertal
AVMs, and again at the end ofadolescence. For
persons from families without such a history,
pulmonary screening shouldbeconsideredbutis
lessclearlyindicated.Astherehavebeencasesof
life threatening pulmonary haemorrhage in the
third trimester of pregnancy, affected women
should have pulmonary screening before
conception. Anyone in whom apulmonary AVM
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is found should undergo helical computer
tomography every five years to rule out the
possible growth ofresidual malformations inthe
intervening period.
Particular care maybe needed to ensure
appropriate screening investigations are
preformedastheneedfortheseparticularlyarises
at a time when transition is being made from
paediatric to adult clinics.
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